These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 31195303

  • 1. A pH-responsive platform combining chemodynamic therapy with limotherapy for simultaneous bioimaging and synergistic cancer therapy.
    Xiao J, Zhang G, Xu R, Chen H, Wang H, Tian G, Wang B, Yang C, Bai G, Zhang Z, Yang H, Zhong K, Zou D, Wu Z.
    Biomaterials; 2019 Sep; 216():119254. PubMed ID: 31195303
    [Abstract] [Full Text] [Related]

  • 2. A nanoselenium-coating biomimetic cytomembrane nanoplatform for mitochondrial targeted chemotherapy- and chemodynamic therapy through manganese and doxorubicin codelivery.
    Xiao J, Yan M, Zhou K, Chen H, Xu Z, Gan Y, Hong B, Tian G, Qian J, Zhang G, Wu Z.
    J Nanobiotechnology; 2021 Jul 30; 19(1):227. PubMed ID: 34330298
    [Abstract] [Full Text] [Related]

  • 3. Bovine serum albumin-templated nanoplatform for magnetic resonance imaging-guided chemodynamic therapy.
    Tang W, Gao H, Ni D, Wang Q, Gu B, He X, Peng W.
    J Nanobiotechnology; 2019 May 20; 17(1):68. PubMed ID: 31109332
    [Abstract] [Full Text] [Related]

  • 4. Metal-organic cage as a theranostic nanoplatform for magnetic resonance imaging guided chemodynamic therapy.
    Yin P, Sun D, Deng Y, Zhu X, Wang Y, Yang J, Feng X.
    Theranostics; 2024 May 20; 14(12):4861-4873. PubMed ID: 39239515
    [Abstract] [Full Text] [Related]

  • 5. Biodegradable Biomimic Copper/Manganese Silicate Nanospheres for Chemodynamic/Photodynamic Synergistic Therapy with Simultaneous Glutathione Depletion and Hypoxia Relief.
    Liu C, Wang D, Zhang S, Cheng Y, Yang F, Xing Y, Xu T, Dong H, Zhang X.
    ACS Nano; 2019 Apr 23; 13(4):4267-4277. PubMed ID: 30901515
    [Abstract] [Full Text] [Related]

  • 6. In Situ Synthesis of FeOCl in Hollow Dendritic Mesoporous Organosilicon for Ascorbic Acid-Enhanced and MR Imaging-Guided Chemodynamic Therapy in Neutral pH Conditions.
    Li T, He F, Liu B, Jia T, Shao B, Zhao R, Zhu H, Yang D, Gai S, Yang P.
    ACS Appl Mater Interfaces; 2020 Dec 23; 12(51):56886-56897. PubMed ID: 33290033
    [Abstract] [Full Text] [Related]

  • 7. Positive feedback nanoamplifier responded to tumor microenvironments for self-enhanced tumor imaging and therapy.
    Zhang Y, Lin L, Liu L, Liu F, Sheng S, Tian H, Chen X.
    Biomaterials; 2019 Sep 23; 216():119255. PubMed ID: 31229855
    [Abstract] [Full Text] [Related]

  • 8. Manganese-Based Nanoplatform As Metal Ion-Enhanced ROS Generator for Combined Chemodynamic/Photodynamic Therapy.
    Wang P, Liang C, Zhu J, Yang N, Jiao A, Wang W, Song X, Dong X.
    ACS Appl Mater Interfaces; 2019 Nov 06; 11(44):41140-41147. PubMed ID: 31603650
    [Abstract] [Full Text] [Related]

  • 9. Mild Hyperthermia-Enhanced Enzyme-Mediated Tumor Cell Chemodynamic Therapy.
    Liu X, Liu Y, Wang J, Wei T, Dai Z.
    ACS Appl Mater Interfaces; 2019 Jul 03; 11(26):23065-23071. PubMed ID: 31252482
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Engineering H2O2 Self-Supplying Nanotheranostic Platform for Targeted and Imaging-Guided Chemodynamic Therapy.
    Han Y, Ouyang J, Li Y, Wang F, Jiang JH.
    ACS Appl Mater Interfaces; 2020 Jan 08; 12(1):288-297. PubMed ID: 31834761
    [Abstract] [Full Text] [Related]

  • 12. Tumor pH-responsive metastable-phase manganese sulfide nanotheranostics for traceable hydrogen sulfide gas therapy primed chemodynamic therapy.
    He T, Qin X, Jiang C, Jiang D, Lei S, Lin J, Zhu WG, Qu J, Huang P.
    Theranostics; 2020 Jan 08; 10(6):2453-2462. PubMed ID: 32194812
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interfacial engineered gadolinium oxide nanoparticles for magnetic resonance imaging guided microenvironment-mediated synergetic chemodynamic/photothermal therapy.
    Zhao Z, Xu K, Fu C, Liu H, Lei M, Bao J, Fu A, Yu Y, Zhang W.
    Biomaterials; 2019 Oct 08; 219():119379. PubMed ID: 31376746
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clearable Theranostic Platform with a pH-Independent Chemodynamic Therapy Enhancement Strategy for Synergetic Photothermal Tumor Therapy.
    Chen Q, Luo Y, Du W, Liu Z, Zhang S, Yang J, Yao H, Liu T, Ma M, Chen H.
    ACS Appl Mater Interfaces; 2019 May 22; 11(20):18133-18144. PubMed ID: 31046230
    [Abstract] [Full Text] [Related]

  • 18. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy.
    Wang Z, Liu B, Sun Q, Dong S, Kuang Y, Dong Y, He F, Gai S, Yang P.
    ACS Appl Mater Interfaces; 2020 Apr 15; 12(15):17254-17267. PubMed ID: 32227859
    [Abstract] [Full Text] [Related]

  • 19. Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reactions.
    Tang Z, Liu Y, He M, Bu W.
    Angew Chem Int Ed Engl; 2019 Jan 21; 58(4):946-956. PubMed ID: 30048028
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.